Media headlines about R1 RCM (NASDAQ:RCM) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. R1 RCM earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned headlines about the financial services provider an impact score of 47.6828701877475 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s analysis:

Several research analysts recently commented on the company. BidaskClub raised R1 RCM from a “hold” rating to a “buy” rating in a research note on Thursday, January 11th. Zacks Investment Research downgraded R1 RCM from a “hold” rating to a “sell” rating in a research note on Wednesday, January 17th. Finally, Robert W. Baird reissued a “hold” rating and issued a $7.00 price objective on shares of R1 RCM in a research note on Monday, February 26th.

Shares of R1 RCM (NASDAQ RCM) opened at $6.31 on Friday. R1 RCM has a 52 week low of $2.32 and a 52 week high of $6.75. The stock has a market capitalization of $651.00, a price-to-earnings ratio of -24.27 and a beta of -0.66.

TRADEMARK VIOLATION WARNING: “Somewhat Positive Press Coverage Somewhat Unlikely to Affect R1 RCM (RCM) Stock Price” was published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at

R1 RCM Company Profile

R1 RCM Inc is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship.

Insider Buying and Selling by Quarter for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with's FREE daily email newsletter.